North America is anticipated to hold a significant share of the pathological examination market, supported by advanced healthcare systems, increasing investments in diagnostic technologies, and growing adoption of automated pathology solutions. The region’s focus on early disease detection and improving diagnostic accuracy is expected to drive market growth through 2031. The Pathological...